Janaki Deepak
Articles
-
Nov 1, 2023 |
frontiersin.org | Qin Chen |Petros Christopoulos |Janaki Deepak |Giulio Rossi
Highlights1. EML4-ALK+ Neuroendocrine lung cancer treated with ALK-TKI inhibitors showed a rapid response;2. Large cell Neuroendocrine cancer patients with ALK fusion are mostly nonsmoking, young, and female;3. Routine ALK IHC is recommended in advanced large-cell neuroendocrine cancer patients.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →